MarketBeat Instant News Alerts 2 hours agoKiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock Price Expected to Rise, Wells Fargo & Company Analyst SaysMarketBeatWells Fargo & Company lifted their price target on shares of Kiniksa Pharmaceuticals International from $57.00 to $74.00 and gave the company an "overweight" rating in a research note on Monday.NASDAQ:KNSARead Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says2 hours agoWells Fargo & Company Issues Positive Forecast for Universal Health Services (NYSE:UHS) Stock PriceMarketBeatWells Fargo & Company upped their price objective on Universal Health Services from $165.00 to $166.00 and gave the company an "equal weight" rating in a research report on Monday.NYSE:UHSRead Wells Fargo & Company Issues Positive Forecast for Universal Health Services (NYSE:UHS) Stock Price2 hours agoHCA Healthcare (NYSE:HCA) Given New $428.00 Price Target at Wells Fargo & CompanyMarketBeatWells Fargo & Company reduced their target price on shares of HCA Healthcare from $436.00 to $428.00 and set an "equal weight" rating for the company in a research note on Monday.NYSE:HCARead HCA Healthcare (NYSE:HCA) Given New $428.00 Price Target at Wells Fargo & Company2 hours agoKeefe, Bruyette & Woods Reaffirms Market Perform Rating for Sezzle (NASDAQ:SEZL)MarketBeatKeefe, Bruyette & Woods reiterated a "market perform" rating and set a $190.00 price target (up from $115.00) on shares of Sezzle in a report on Monday.NASDAQ:SEZLRead Keefe, Bruyette & Woods Reaffirms Market Perform Rating for Sezzle (NASDAQ:SEZL)2 hours agoKeefe, Bruyette & Woods Reaffirms Market Perform Rating for Porch Group (NASDAQ:PRCH)MarketBeatKeefe, Bruyette & Woods reissued a "market perform" rating and set a $16.25 target price (up from $13.00) on shares of Porch Group in a research note on Monday.NASDAQ:PRCHRead Keefe, Bruyette & Woods Reaffirms Market Perform Rating for Porch Group (NASDAQ:PRCH)2 hours agoAflac (NYSE:AFL) Stock Price Expected to Rise, Keefe, Bruyette & Woods Analyst SaysMarketBeatKeefe, Bruyette & Woods increased their price objective on Aflac from $115.00 to $120.00 and gave the company a "market perform" rating in a report on Monday.NYSE:AFLRead Aflac (NYSE:AFL) Stock Price Expected to Rise, Keefe, Bruyette & Woods Analyst Says Trending News1Rackspace Technology Cuts 2026 Outlook as $250M Stock Sale Fuels AI Push2Nebius Group (NASDAQ:NBIS) Shares Up 10.9% - Here's Why3Susquehanna Issues Pessimistic Forecast for Plug Power (NASDAQ:PLUG) Stock Price4Fannie Mae (OTCMKTS:FNMA) Trading 5.7% Higher - Here's Why5HB Wealth Management LLC Makes New Investment in Nebius Group N.V. $NBIS6Lloyds Banking Group (LON:LLOY) Share Price Crosses Above Two Hundred Day Moving Average - Here's What Happened7United Parcel Service (NYSE:UPS) Stock Rating Upgraded by Stephens8Archer Aviation (NYSE:ACHR) Shares Down 2.4% - Here's What Happened All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoBTIG Research Has Lowered Expectations for Coinbase Global (NASDAQ:COIN) Stock PriceMarketBeatNASDAQ:COINRead BTIG Research Has Lowered Expectations for Coinbase Global (NASDAQ:COIN) Stock Price2 hours agoNeedham & Company LLC Begins Coverage on Park Aerospace (NYSE:PKE)MarketBeatNYSE:PKERead Needham & Company LLC Begins Coverage on Park Aerospace (NYSE:PKE)2 hours agoCandel Therapeutics (NASDAQ:CADL) Coverage Initiated by Analysts at Stifel NicolausMarketBeatNASDAQ:CADLRead Candel Therapeutics (NASDAQ:CADL) Coverage Initiated by Analysts at Stifel Nicolaus2 hours agoHC Wainwright Forecasts Strong Price Appreciation for TG Therapeutics (NASDAQ:TGTX) StockMarketBeatNASDAQ:TGTXRead HC Wainwright Forecasts Strong Price Appreciation for TG Therapeutics (NASDAQ:TGTX) Stock2 hours agoHemab Therapeutics (NASDAQ:COAG) Price Target Raised to $52.00 at HC WainwrightMarketBeatNASDAQ:COAGRead Hemab Therapeutics (NASDAQ:COAG) Price Target Raised to $52.00 at HC Wainwright2 hours agoApyx Medical (NASDAQ:APYX) Now Covered by HC WainwrightMarketBeatNASDAQ:APYXRead Apyx Medical (NASDAQ:APYX) Now Covered by HC Wainwright2 hours agoBiogen (NASDAQ:BIIB) Upgraded to Buy at Truist FinancialMarketBeatNASDAQ:BIIBRead Biogen (NASDAQ:BIIB) Upgraded to Buy at Truist Financial2 hours agoHC Wainwright Raises BridgeBio Pharma (NASDAQ:BBIO) Price Target to $120.00MarketBeatNASDAQ:BBIORead HC Wainwright Raises BridgeBio Pharma (NASDAQ:BBIO) Price Target to $120.002 hours agoBTIG Research Reiterates Buy Rating for Wingstop (NASDAQ:WING)MarketBeatNASDAQ:WINGRead BTIG Research Reiterates Buy Rating for Wingstop (NASDAQ:WING)2 hours agoSaia (NASDAQ:SAIA) Upgraded by Bank of America to "Buy" RatingMarketBeatNASDAQ:SAIARead Saia (NASDAQ:SAIA) Upgraded by Bank of America to "Buy" Rating2 hours agoBTIG Research Reiterates "Buy" Rating for Oruka Therapeutics (NASDAQ:ORKA)MarketBeatNASDAQ:ORKARead BTIG Research Reiterates "Buy" Rating for Oruka Therapeutics (NASDAQ:ORKA)2 hours agoPapa John's International (NASDAQ:PZZA) Earns Underperform Rating from Bank of AmericaMarketBeatNASDAQ:PZZARead Papa John's International (NASDAQ:PZZA) Earns Underperform Rating from Bank of America2 hours agoBlackRock Tchnlgy nd Prvt Eqty Trm Trst Plans Monthly Dividend of $0.05 (NYSE:BTX)MarketBeatNYSE:BTXRead BlackRock Tchnlgy nd Prvt Eqty Trm Trst Plans Monthly Dividend of $0.05 (NYSE:BTX)2 hours agoDiageo (LON:DGE) Insider Purchases £150.50 in StockMarketBeatLON:DGERead Diageo (LON:DGE) Insider Purchases £150.50 in Stock2 hours agoSpyre Therapeutics (NASDAQ:SYRE) Stock Price Expected to Rise, Mizuho Analyst SaysMarketBeatNASDAQ:SYRERead Spyre Therapeutics (NASDAQ:SYRE) Stock Price Expected to Rise, Mizuho Analyst Says2 hours agoYork Space Systems (NYSE:YSS) Earns Buy Rating from Jefferies Financial GroupMarketBeatNYSE:YSSRead York Space Systems (NYSE:YSS) Earns Buy Rating from Jefferies Financial Group2 hours agoJPMorgan Chase & Co. Has Lowered Expectations for Western Union (NYSE:WU) Stock PriceMarketBeatNYSE:WURead JPMorgan Chase & Co. Has Lowered Expectations for Western Union (NYSE:WU) Stock Price2 hours agoMedpace (NASDAQ:MEDP) Given New $586.00 Price Target at MizuhoMarketBeatNASDAQ:MEDPRead Medpace (NASDAQ:MEDP) Given New $586.00 Price Target at Mizuho2 hours agoVerra Mobility (NASDAQ:VRRM) Upgraded at JPMorgan Chase & Co.MarketBeatNASDAQ:VRRMRead Verra Mobility (NASDAQ:VRRM) Upgraded at JPMorgan Chase & Co.2 hours agoAmerican Express (NYSE:AXP) Rating Increased to Overweight at JPMorgan Chase & Co.MarketBeatNYSE:AXPRead American Express (NYSE:AXP) Rating Increased to Overweight at JPMorgan Chase & Co.2 hours agoIQVIA (NYSE:IQV) Given New $230.00 Price Target at MizuhoMarketBeatNYSE:IQVRead IQVIA (NYSE:IQV) Given New $230.00 Price Target at Mizuho2 hours agoAlkermes (NASDAQ:ALKS) Receives Neutral Rating from JPMorgan Chase & Co.MarketBeatNASDAQ:ALKSRead Alkermes (NASDAQ:ALKS) Receives Neutral Rating from JPMorgan Chase & Co.2 hours agoMizuho Raises Charles River Laboratories International (NYSE:CRL) Price Target to $230.00MarketBeatNYSE:CRLRead Mizuho Raises Charles River Laboratories International (NYSE:CRL) Price Target to $230.002 hours agoLegend Biotech (NASDAQ:LEGN) Given "Neutral" Rating at JPMorgan Chase & Co.MarketBeatNASDAQ:LEGNRead Legend Biotech (NASDAQ:LEGN) Given "Neutral" Rating at JPMorgan Chase & Co. Featured Articles and OffersSK Hynix’s Nasdaq Listing Could Reset the AI Memory TradeBy Thomas Hughes | July 7, 2026Trump's gold order: the announcement they won't put on the front pageFrom Reagan Gold Group (Ad)Rocket Lab’s Stock Drop Comes With a Bullish TwistBy Ryan Hasson | July 10, 2026AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion TargetBy Jeffrey Neal Johnson | July 10, 2026A Market Panic Just Discounted the AI Highway's TollboothBy Jeffrey Neal Johnson | July 8, 2026Legendary Stock Bull Says: “Brace for an Epic Price Crash”From The Oxford Club (Ad)PriceSmart Stock Eyes $220 as Chile Expansion Fuels GrowthBy Thomas Hughes | July 9, 2026IQM's Nasdaq Debut Could Change the Quantum Race for D-WaveBy Nathan Reiff | July 10, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 313 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
